Keith Joyce encountered Leucovorina last December, while trying to find ways to improve his autistic grandson of the old and a half years old, Jose. In the next few months, he spent drug research and talked to neurologists. In April, he sent his research to Jose Development Expert in Development, who agreed to prescribe the drug.
In five months since treatment began, Jose left that he was usually non-verbally annoyed.
“Within a few days, I started to see the difference:” Joyce says wired. Before taking Leucovorin, “he fought with two words of the sentence, and last night I had three or four minutes of discussion about the family with him.”
Joyce wanted to share his research with others because there were such several resources on the net, so Leucovorin for autism group on Facebook began in May.
At first, there were interests in the group, and until August joined about 8,000 people, says Joyce. But then the news came that the Trump administration and the American Health Secretary Robert F. Kennedy Jr. Recommended Leucovorins as possible treatment for autism – group exploded. In the week following the announcement in Makars, the membership of the Joyce Group jumped over 60,000 people.
Even before the official announcement was made, tens of thousands of new members joined the basis of drug guesses.
Then, last month, President Donald Trump pushed allegations without a fairy tale that the active ingredient in Tylenol and the vaccine can contribute to the diagnosis of autism. The head of the FDA Marty Makary announced on 22. September that the Agency approved the use of Leucovorin to treat the lack of folate in the brain, a shortcoming that have some people with autism symptoms.
“Leucovorin is something that has been prescribed for many years of out-label for autistic people,” says Matthew Lerner, Lifestyle Course Program Research Program at the Trexel Institute at Drexel University. “To date there were small research studies, also with pretty inconsistent findings. But honestly, we don’t know much, even from those studies, in terms of what would be optimal dosing, what would be the optimal time on it.”
